Objective: To study the effect of the Lactobacillus plantarum (LP) enteral feeding on the gut permeability and sepsis in the patients with acute pancreatitis. Subjects: Seventy-six subjects who stayed over 1 week in the hospital completed the study. Subjects were not treated with any lactobacillus supplement before the intervention. Methods: Seventy-six patients with acute pancreatitis were randomly divided into two groups, parenteral nutrition (PN) group (n ¼ 38) and ecoimmunonutrition (EIN) group supplied by LP enteral feeding (n ¼ 36). The acute physiology and chronic health evaluation score, Balthazar CT score, CRP, fecal bacterial species and DNA fingerprint profiles as well as the potentially pathologenic organisms in nasogastric aspirate were determined on the day of admission and on the 8 day. The intestinal permeability was assessed by measurement of the ratio of lactulose/rhamnose on the day of admission and on days 5 and 8. The rate of organ failure, septic complications and death cases were evaluated at the 8 day. Results: Following 7 days treatment, 38.9% patients in the EIN group were colonized with multiple organisms compared to 73.7% in the PN group (Po0.01), and 30.6% patients in the EIN grew potentially pathogenic organisms compared to 50% patients in PN group (Po0.05). The fecal bacterial DNA fingerprint profiles were less, the amount of lactobacteria and bifydobacteria decreased, and the amount of enterococci increased in PN group as compared with EIN group, Po0.05. By day 8, the lactulose/rhamnose ratio in EIN group were lower than that in PN group at days 5 and 8, Po0.05. The patients with LP got a better clinical outcomes as compared with the patients with PN. Conclusion: EIN enteral feeding can attenuate disease severity, improve the intestinal permeability and clinical outcomes.
Introduction
Despite recent advances in intensive care management, the mortality rate of severe acute pancreatitis (SAP) remains high, and secondary infection of pancreatic necrosis is associated with particularly high mortality rates as high as 40% (Bradley, 1993; Miller et al., 1994; Branum et al., 1998) . Sepsis and multiple organ failure, mainly owing to pancreatic or peripancreatic infection, have emerged as the most serious complications and now account for more than 80% of deaths. Experimental studies indicated that pancreatic infection in SAP appeared to be due to translocation of bacteria from the gut to mesenteric lymph nodes, peritoneal fluid and blood, then from these sites to the pancreas itself. Several experimental studies revealed that acute pancreatitis (AP) promotes bacterial translocation, which in turn leads to infection of the pancreas and septic complications (Foitzik et al., 1994; Kazantsev et al., 1994) . The main mechanisms that governed the processes of bacterial translocation in SAP are probably related to the over-growth of enteric flora due to intestinal dysfunction, damage to intestinal permeability and impairment of host immunity (Foitzik et al., 1995) . Furthermore, endothelial and epithelial barrier functions are important to protect against potential invasion of enteric microorganisms, and their function may also be essential to prevent the development of multiple organ dysfunction (Andersson et al., 1998; Osman et al., 1998) . How to prevent bacterial translocation and how to protect the intestinal mucosa from being damaged might be a key to limiting the septic complication in SAP. Early enteral nutrition is known to reduce septic morbidity in conditions such as thermal injury, trauma and major surgery. Adherence to the old belief that pancreatic rest is important has significantly delayed the use of early enteral nutrition in severe pancreatitis. A large controlled study of patients with AP showed that enteral nutrition significantly reduced septic complications, but made no difference to the rate of multiple organ failure or death (Meier et al., 2006) .
In recent years, several trials with probiotics enteral feeding have shown a significant reduction of infectious complications both in AP and in patients undergoing major abdominal surgery (Olah et al., 2002; Rayes et al., 2002a, b) . A well-designed placebo-controlled trial with Lactobacillus plantarum (LP) in patients with AP showed very interesting results: a significant reduction of infected pancreatic necrosis (1/22 versus 7/23 infected necrosis) (Olah et al., 2002) . In the light of gathered data, it has been suggested that probiotics have antibacterial and immunomodulatory effects and could offer an alternative in the prevention and treatment of secondary infections in AP, by decreasing bacterial translocation (Fuller and Gibson, 1997) . The present study was undertaken to investigate the effect of LP enteral feeding on the gut permeability and septic complications in the patients with AP.
Methods

Study design
This is a prospective, randomized, single-blinded, paralleldesign clinical trial. Seventy-six patients with AP who had not undergone surgery in the surgical and gastroenterological department of the Affiliated Shanghai Sixth People's Hospital to the Shanghai Jiao Tong University between February 2002 and March 2006.
Selection criteria
Inclusion criteria: (1) Age between 25 and 75 years, (2) Serum amylase was greater than 1000 IU with clinical evidence of AP, (3) The score of the second acute physiology and chronic health evaluation (APACHE II) was evaluated for all patients. APACHE II was over 8, the average score was 8.870.6. The Balthazar's CT score were over grade II (4) the average score was 4.670.5. (4) Administration of the study product is started within 48 h after onset of abdominal pain.
Exclusion criteria: (1) Post-ERCP pancreatitis, (2) Malignancy, (3) Infection/sepsis caused by a second disease, intraoperative diagnosis of pancreatitis, (4) Use of probiotics during the study. (5) Hypertriglyceridemia 410 mmol/l on the day of admission. (6) Life-threatening intercurrent disease.
Randomization and blinding
Following recruitment, patients were to be allocated in an ascending order of random numbers, and no number is to be missed or exchanged with a block of patients. Patients with AP matching the criteria for eligibility will be enrolled in the study and randomized to one of the following groups: treatment group 1 (parenteral nutrition (PN) group) received standard support, and 100 ml of 0.9% normal saline were infused daily through the nasojejunal tube. Treatment group 2 (ecoimmunonutrition (EIN) group) supported by the PN combined with enteral nutrition solution, and 100 ml of probiotics containing living LP were infused daily through the nasojejunal tube.
Interventions and study groups
The two groups were isonitrogenous and isocaloric. Each patient received daily amino acids (Novamin, Wuxi City, China, SSPC) containing 0.15 g of nitrogen per kilogram body weight, and nonprotein calories was supported by 25 kCal per kilogram body weigh and supplied by 50% glucose and 20% Intralipid (Energy Index 1:1). Multivitamins and electrolytes were also included in PN solution.
EIN group was supported by the PN combined with enteral nutrition solution -Nutrison (Production of Nutricia Com. Ltd, Wuxi City, China). A 500 ml Nutrison and 250 ml 0.9% saline through jejunal tube was infused for 7 days. The enteral feeding was introduced at 30 ml/h and the rate increased incrementally, depending on tolerance, at up to 50-75 ml/h. The regimen was based on 4, 5 hourly feeds with 1 h rest between each. The infusion rate was controlled by a computer-programmed pump (Nutricia). During the period of enteral feeding supporting, the amount of insufficiency of calories and nitrogen were supplemented by partial PN. A 100 ml of probiotics containing living LP (activity 1 Â 10 8 cfu/ml) (Shanghai Jiaotong University Only Inc., Shanghai, China) were infused daily through the nasojejunal tube for 7 days. Other adjuvant therapy was the same in the two patients group, and followed generally accepted principle. No attempt was made to reduce gastric acidity, as low pH was considered important for control of microbial overgrowth in the stomach.
Clinical management
Seventy-six patients with AP who had not undergone surgery participated into the trial. After relieving possible ileus (nasogastric tube withdrawn, resumption of flatus7stools), a self-propelled nasojejunal tube (Nutricia) was inserted. This tube has a spiral extremity, which migrates spontaneously into the jejunum. The objective was to place the tube beyond the duodenojejunal flexure. When the tube failed to migrate into jejunal, despite the use of a prokinetic (metoclopramide), the tube was placed, under general anesthesia, by endoscopic control.
Patients received their 7-day nutritional support according to randomization. On completion of their nutritional support period, patients were re-evaluated in an identical fashion to that outlined above for the clinical, radiological and laboratory parameters. Following this, continuation of nutritional support or reintroduction of a normal dietary intake was undertaken according to the wishes of the attending clinician. Seventy-six patients received 28 days follow-up after finishing the trial, and no patients occurred adverse event.
End points
The primary end point was the development of infective complication. Secondary end points were non-infective complication, mortality and duration of hospital stay. Third end points were nasogastric aspirate bacterial culture, fecal sample bacterial culture and DNA fingerprint profiles, and intestinal permeability.
The clinical signs of systemic inflammatory response syndrome (SIRS) and development of multiple organ dysfunction syndrome (MODS) and pulmonary complications were analyzed at day 8. SIRS and MODS were defined according to the criteria of the 1991 Consensus Conference of the American College of Chest Physicians and the Society of Critical Care Medicine. SIRS is defined as two or more of the following conditions (Baue, 2006) : (1) temperature greater than 381C or less than 361C; (2) heart rate greater than 90 beats/min; (3) respiratory rate greater than 20 breaths/min or PaCO2 less than 32 torr; (4) white blood cell greater than 12 000 cells mm À3 or less than 4000 cells mm
À3
or greater than 10% immature (band) forms. MODS was defined by Marshall et al. (1995) . Catheter-related complications is defined as followed (Blot et al., 1999) : (1) symptoms of sepsis disappearing within 48 h after catheter removal (unless a remote focus of infection, secondary to catheterrelated infections, was responsible for the persistence of sepsis); and (2) a positive quantitative catheter-tip culture (410 3 cfu/ml) and isolation of the same microorganism from the catheter and peripheral venous blood (at least one positive peripheral blood culture, except for coagulasenegative staphylococci, for which two positive blood cultures were required). Pulmonary complications in SAPs are defined as follows (Pastor et al., 2003) : (1) alveolar edema on the chest radiograph; (2) progressive hypoxemia; (3) pleural effusions; and (4) atelectasis.
Sample size and power calculation AP is associated with an infective complication rate of 80%, and based on the results achieved in a previous study on 30 patients, the aim of this study was to reduce this complication rate by 50% in the group received LP. On the basis of this, a sample size of 70 (35 in each group) was necessary to show this difference at a 5% significant with a power of 80%, allowing for a drop out rate of 10%.
Monitoring
Subjects must be carefully monitored according to the clinical study protocol. Blood samples were taken on the day of admission, and on day 8 thereafter. Plasma albumin, lymphocyte cell count, catheter-related septic complication and positive blood culture were measured during the period of the seven days' study, and death case were also determined at the day 8.
Special methods used Nasogastric aspirate sample bacterial culture. Nasogastric aspirate sample (1 ml) was placed in an anaerobic glove box within 1 h after collection and then in prereduced brainheart infusion broth and diluted from 10-fold to 10 À8 in the same medium (Qin et al., 2005) . The dilutions were removed from the anaerobic glove box and were used to inoculate (100 ml inocula) plates which contained the following media and were incubated aerobically at 371C: supplemented brucella blood agar, MacConkey agar (Difco, Franklin lakes, NJ, USA), bile esculin azide agar (Difco). Ten colonies were selected randomly from a dilution agar plate containing about 100 colonies. The bacterium colonies were counted and identified by Microscan Autoscan-4 (Dade Behringcom, Sacramento, CA, USA). All Gram-negative bacteria, pseudomonas species and staphylococcus aureus were considered as potentially pathogenic organisms.
Fecal bacterial anaerobic culture. The fecal sample (1 g) was placed in an anaerobic glove box within 1 h after collection and then homogenized in prereduced brain-heart infusion broth and diluted from 10-fold to 10 À8 in the same medium (Baue, 2006) . A 100 ml of each dilution were spread onto the surfaces of plates which contained the following agar media and were incubated anaerobically at 371C: supplemented brucella blood agar (2 days, total anaerobic CFU), bacteroides bile esculin agar (2 days), egg yolk agar (after equal volumes of 95% ethanol were added to the dilutions and the preparations stood for 30 min to select for clostridial spores) and Rogosa SL agar (Difco) (2 days for lactobacilli and 4 days for bifidobacteria, after Lactobacillus colonies were marked at 2 days). The dilutions were removed from the anaerobic glove box and were used to inoculate (100 ml inocula) plates which contained the following media and were incubated aerobically at 371C: supplemented brucella blood agar (2 days, total aerobic CFU), MacConkey agar (Difco) (1 day, enterobacteria), bile esculin azide agar (Difco) (1 day, enterococci). To analyze the total lactobacillus population, ten colonies were selected randomly from a dilution agar plate containing about 100 colonies. The bacterium colonies were counted and identified by Microscan Autoscan-4 (Dade Behringcom).
Gut bacterial DNA fingerprint profiles. The fecal samples from the patients and the healthy volunteers (n ¼ 10) were also examined by polymerase chain reaction (PCR)-denaturing gradient gel electrophoresis (DGGE) profiles. To extract bacterial DNA, 1 ml of fecal homogenate in pH 7.0 phosphate buffer (the buffer used for the azoreductase assay) was centrifuged at 14 600 Â g for 5 min (51C). DNA was extracted from the resulting pellet with a Fast DNA kit (BIO 101,Vista, CA, USA) by using CLS-TC (a cell lysis solution used for animal tissues and bacteria). The V2-V3 region of the 16S rDNA gene (positions 339-539 in the Escherichia coli gene) of bacteria in the fecal samples was amplified by using primers bacteria ITS PS2 (5
. PCR was performed with 0.2-ml tubes by using a PCR Express thermal cycler (Hybaid, Teddington, UK). Each reaction mixture (50 ml) contained reaction buffer, 10 mM (final concentration); Tris-HCl, 2.5 mM (final concentration); MgCl 2 , 50 mM (final concentration); KCl (pH8.3), and each deoxy-nucleoside triphosphate at a concentration of 200 mmol/l, 20 pmol of each primer, 1 ml of fecal DNA and 2.5 U of Taq DNA polymerase (Boehringer, Mannheim, Germany). The following amplification program was used: 941C for 3 min, 30 cycles consisting of 941C for 30 s, 561C for 30 s and 681C for 60 s, and then 7 min at 681C. DGGE was performed by using a DCode universal mutation detection system (Bio-Rad, Richmond, CA, USA) and gels that were 16 Â 16 cm by 1 mm; 6% polyacrylamide gels were prepared and electrophoresed with 1 Â TAE buffer prepared from 50 Â TAE buffer (2 mol/l Tris base, 1 mol/l glacial acetic acid, 50 mmol/l EDTA). The denaturing gradient was formed by using two 6% acrylamide (acrylamide/bisacrylamide ratio, 37.5:1) stock solutions (Bio-Rad). The gels contained a 22-55% gradient of urea and formamide that increased in the direction of electrophoresis. A 100% denaturing solution contained 40% (vol/vol) formamide and 7.0 M urea. Electrophoresis was performed at 130 V (constant voltage) and 601C for about 4.5 h. Electrophoresis was stopped when a xylene cyanol dye marker reached the bottom of a gel. The gels were stained with an ethidium bromide solution (5 mg/ml) for 20 min, washed with deionized water, and reviewed by UV transillumination (Qin et al., 2005) .
Intestinal permeability. Small intestinal permeability was measured on days 0, 5 and 8 using the lactulose/rhamnose (L/R) dual sugar probe technique. Patients were administered 5 g of lactulose and 1 g rhamnose after an overnight fast. Urine was collected for 5 h and the concentration of urinary sugars assayed using HPLC. A L/R ratio of greater than 0.05 in 5-h urine collection was indicative of increased intestinal permeability (McNaught et al., 2005) .
Statistical analysis
The data were analyzed on an intention to treat basis with SPSS for Windows Release 12.0 software (www.cdc.gov/ epinfo). The w 2 -test and Student's t-test (unpaired), and the Fisher's exact test were used to determine the significance between groups. The experimental data were expressed as x (means)7s.d. of the sample. P-value below 0.05 was considered statistically significant.
Ethics and consent
The study was approved by the Hospital Ethics Committee and written informed consent was obtained from all participants. The study was carried out in accordance with the Declaration of Helsinki Principles of the World Medical Association (http://www.wma.net/e/policy/b3.htm).
Role of the sources of funding
The sponsors of the study did not have any role in the study design, data collection, analysis and interpretation, writing of the paper or in the decision to submit the paper for publication.
Results
Study sample characteristics
The trial profile is shown in Figure 1 and patient demographics are summarized in Table 1 . There were no significant differences between the two groups with regard to sex, age, body mass index, average nitrogen (g) and calories (kCal) intake per patient per day, etiology of the pancreatitis, and time between onset of symptoms and hospital admission, and in terms APACHE II, Balthazar's CT score, and rate of SIRS and MODS.
Nasogastric aspirates: pH, potentially pathogenic organisms and multiple organisms
The mean values of NG aspirate pH are showed in Table 2 . There was no significant difference in NG pH between the two groups on days 1 and 8. There were no significant differences in the total number of positive isolates in EIN group and PN group at any time point. By day 8, however, only 14 (38.9%) patients in the EIN group were colonized with multiple organisms compared to 28 (73.7%) in the PN group (P ¼ 0.003), and 11 (30.6%) patients in the EIN group grew potentially pathogenic organisms compared to 19 (50%) patients in PN group (P ¼ 0.03).
Intestinal permeability
On the day 5, the patients had an elevated L/R ratio indicative of increased permeability in PN group. By the day 8, the L/R ratio in EIN group were lower than that in PN group at days 5 and 8, P ¼ 0.04 (Table 3) .
The amount of bacterial of fecal in the cecum There were no marked difference of the gut bacterial strains in EIN group as compared with PN group, P40.05. But the amount of lactobacteria and bifydobacteria increased, and the amount of enterococci decreased in EIN group as compared with PN group, P ¼ 0.04 (Table 4) .
Gut bacterials DNA fingerprint profiles
The profiles of the fecal bacterial DNA fingerprint in PN group (lane 1-4: 9 patients fecel sample/lane, mixture with 38 patient fecel) were less than that in EIN group (lane 5-10: 6 patients' fecel sample/lane, mixture with 36 patients' fecel); lanes 11 and 12 were the gut bacterial DNA fingerprint profiles (five patient fecel sample/lane) of the healthy volunteers (Figure 2 ).
Clinical outcomes measures
There were no significant differences between the groups in the extent and frequency of pancreatic necrosis on CT. On the day 8, 14 patients had signs of hypoproteinemia in PN group, 10 in EIN group. Fourteen patients developed SIRS, seven patients developed MODS in PN group, while seven patients in SIRS and four patients in MODS in EIN group, respectively. Nine patients developed pulmonary complications were observed in EIN group, three patients developed pulmonary complications in EIN patients. The occurrence of the catheter-related septic complication (34.21%) were higher than that in EIN group (13.89%), P ¼ 0.03. Analysed 38
Analysed 36
Figure 1 Trial profile. CT scores were not significantly different between the two groups. The mean duration of hospital stay was longer in the PN group than that in EIN group (24.2 versus 20.9 days), but the difference was not statistically significant. No death case occurred (Table 5) .
Discussion
Infection and septic complications are the major factors contributing to the poor outcome in SAP. They cause up to 80% of deaths and occur in 5-10% of patients. It is thought that in the majority of cases infection is caused by bacterial translocation from the gut lumen, a hypothesis which animal experiments have generally supported (Olah et al., 2002; Rayes et al., 2002a) . Unfortunately attempts to confirm the link between bacterial translocation and morbidity and mortality in AP in human beings have been largely unsuccessful (Bradley, 1993; Rayes et al., 2002b) . Experimental studies have shown that bacterial overgrowth occurs very early, within 24 h after onset, in the course of AP and reduction of the bacterial load in the proximal small bowel by intraluminal antibiotics reduces the risk of infection of pancreatic necrosis. Although such changes might occur later in humans, studies of early changes in various immune parameters, cytokines, coagulation factors and growth factors in AP support the concept that early enteral nutrition intervention might be beneficial. Early enteral nutrition is not easy to achieve because many patients arrive in hospital more than 24 h after the onset of AP (Olah et al., 2002) . n ¼ number of patients; * versus PN group D8, t ¼ 2.44, P ¼ 0.003; # versus EIN group D1, t ¼ 1.56, P ¼ 0.03. Positive culture (n(%)) ¼ patients (with Gram-negative bacteria or pseudomonas species or Staphylococcus)/all patients. Multiple organisms (n(%)) ¼ patients (with Gram-negative bacteria and pseudomonas species and staphylococcus aureus)/all patients. The rapid disappearance of commensal flora in AP combined with the overgrowth of potentially pathogenic microorganisms is a reasonable rationale for early supplementation of LP. LP are documented to have strong antiinfectious and immunomodulatory effects. In Hungary, a double-blind, placebo-controlled (Olah et al., 2002) was performed in 45 AP patients. Patients were randomly allocated to either viable LP (group A) or heat-inactivated LP (group B). All patients received a jejunal tube and fiberenriched enteral feeding for 1 week. Treatment was started within 48 h of admission. In the group treated with LP, 5% developed infected pancreatic necrosis (positive aspiration culture) against 30% in the group treated with heatinactivated LP. This study showed that supplementary LP 299 was effective in reducing pancreatitic sepsis and the number of surgical interventions. In our study, 36 patients with LP got a better clinical outcomes than that of 38 patients only supplemented PN. In addition, the change of lymphocyte cell count, SIRS, MODS, pulmonary complications, catheter-related septic complication in EIN group were lower as compared with PN group; the cases of positive blood culture and antibiotic therapy were decreased; gastrointestinal bleeding, paralytic ileus and defecation (times) were improved in EIN group. Following 7 days of LP enteral feeding, there was a significant reduction in serum CRP and APACHE II scores. The mean duration of hospital stay was longer in the PN group than that in EIN group (24.2 versus 20.9 days), but the difference was not statistically significant. Similar results were obtained in patients undergoing liver transplantation (Rayes et al., 2002b) : 4 of 31 patients who received live LP 299 and fiber developed infection, compared with 11 of 34 given heat-killed LP 299 and fiber developed infection, and 15 of 23 treated with selective bowel decontamination (P ¼ 0.017). In a study of patients undergoing gastric and pancreatic surgery (Andersson et al., 1998) , the 1-month sepsis rate with LP 299 was 1 of 15, compared with 3 of 17 patients receiving heat-inactivated LP 299, 8 of 16 patients who received PN with fiber and no LP 299 developed sepsis (P ¼ 0.001).
Traditionally, the fecal microflora has been analyzed by using bacteriological culture methods. It has been claimed that approximately 88% of the total microscopic counts of bacterial cells can be cultivated from feces when appropriate techniques are employed (Fuller and Gibson, 1997; Qin et al., 2005) . The results of the fecal anaerobic culture showed that there were not marked differences of the gut bacterial strains in EIN group as compared with PN group. But the amount of lactobacteria and bifidobacteria increased, and of enterococci decreased in EIN group as compared with PN group. However, because of conditions of the anaerobic culture was limited, only some local bacterium were determined by quantitative analysis, and could not show the whole profiles of gut preponderant bacterium colony. Fortunately, analysis of terrestrial and aquatic ecosystems in more recent years has benefited from the use of molecular biological methods with which community profiles have been established. The molecular methods involve the amplification by PCR of 16S ribosomal RNA genes (16S rDNA) from microbial DNA extracted from samples collected from particular habitats (Bengmark, 2002; Qin et al., 2005) . Summaries of useful molecular typing (genetic DNA fingerprinting) methods provided direct response to the gut bacterial strains balance (Bengmark, 2002) . We measured the impact of consumption of this LP on the fecal microflora by using PCR-DGGE, the results showed that the gut bacterium variety were improved by measuring DNA fingerprint profiles in EIN group. Our results suggested that the patients with AP received PNdeveloped gut microflora imbalance, but it could be improved by LP enteral feeding.
Results of the current study confirm that colonization of the proximal gastrointestinal tract is common in critically ill patients (Marshall et al., 1988) . Indeed, 88.9-92.1% of the subject had positive nasogastric aspirates at the time of study entry. LP enteral feeding significantly altered the microbial composition of nasogastric aspirates, reducing the carriage of pathogenic bacterial and multiple organisms, it was observed a significantly higher rate of septic complications in patients who had growth of potentially pathogenic bacteria in NG aspirates in PN group in this study. Marshall (1993) reported a similar increase in nosocomial infection in critically ill patients with pathological gastric colonization.
Intestinal permeability was abnormal in the patients at the time of entrance into the study. This is in keeping with previously published reports of permeability in critically ill patients (Harris et al., 1992) . Our results suggested that LP administration had good effect on intestinal permeability of the patients with AP. Some probiotics bacteria have previously been shown to modify permeability in animal models. There is evidence to suggest that probiotics help to stabilize the gut microbial environment, enhance systemic and local immune responses, and possibly promote gut mucosal barrier function (Collins and Glenn, 1999; . Use of probiotics has been of therapeutic value in clinical conditions associated with gut barrier dysfunction and inflammatory response (Bengmark, 2001; Isolauri, 2001; Kolida et al., 2002) . The exact mechanism of action of LP in altering gastric microflora and intestinal permeability is not clear. But local and remote actions of probiotic organisms have been suggested. Some studies have shown a reduction in potentially pathogenic organisms even at sites distant to the gut (vagina and nasal cavity) following oral probiotic therapy (Gluck and Olaf Gebbers, 2003; Reid et al., 2003) . One proposed mechanism is that probiotics initiate an immune response in the gut-associated lymphoid tissue, resulting in circulation of primed T and B cells and immune activation at distant mucosal surfaces (Perdigon et al., 1999; .
Some authors have difficulties to administer enteral nutrition in patients with AP due to intestinal dysmotility. In present study, enteral feeding was well tolerated by our patients and did not lead to recurrence or worsening of pain. The feedings were started in the small volumes and slow infusion rates of 1-1.5 ml/min. This was well tolerated and no one had pain during the course of feeding leading to withdrawal of the feedings without any evidence of exacerbation of pancreatitis, because there was no associated hyperamylasemia or clinical or radiologic evidence of worsening of disease.
In conclusion, LP enteral feeding has beneficial effects on maintaining the integrity of intestinal mucosal barrier and microflora, and reducing the incidence of septic complications and the degree of severity in patients with AP. However, it is not possible to tell which compound (enteral nutrition or LP) or both is responsible for the good results. And the way in the next would be to have a group receiving EN alone and compare it with another group receiving EN þ LP. This would help get over the problems of single blinding and would be a true measure of the effects of LP.
